Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2116 (LINC02116)

Target
LINC02116
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

**Long intergenic non-protein coding RNA 2116 (LINC02116)** is a human gene transcribing a long non-coding RNA (lncRNA)[1][7]. It belongs to the class of *long intergenic non-coding RNAs (lincRNAs)*, which are defined as RNA transcripts longer than 200 nucleotides that do not overlap with protein-coding genes[9]. The formal gene symbol is LINC02116 with no widely used aliases or abbreviations beyond this standard nomenclature[7]. The specific biological function, disease association, or interacting partners of LINC02116 are currently not defined in the biomedical literature or gene function databases[1][7]. As is typical of lincRNAs, LINC02116 is presumed to participate in the regulation of gene expression, potentially through effects on chromatin state or gene transcription, but its individual functional roles and mechanisms remain uncharacterized[9]. There is no evidence to date that LINC02116 is a therapeutic target, involved in any specific disease process, or serves as a biomarker or drug target. If your use case is to extract structured information on well-studied targets, note that LINC02116 currently lacks experimental or clinical characterization and does not fit established target classes like enzymes, transporters, or receptors[1][7][9].

Other names
LINC02116
02

Biological functions

Regulation of gene expression (putative)Chromatin architecture modulation (general for lincRNAs)Transcriptional regulation (general for lincRNAs)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2116 (LINC02116).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2116 (LINC02116).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call